Temsujohn 0.2mg Tablet ER
Prescription Required
Product introduction
Temsujohn 0.2mg Tablet ER is an alpha-adrenergic antagonist that is used in the treatment of benign prostatic hyperplasia. It helps to relieve symptoms like difficulty in passing urine. However, it does not decrease the size of the prostate.
is used to treat difficulties in passing urine in patients with enlarged prostate gland
Uses of Temsujohn Tablet ER
Benefits of Temsujohn Tablet ER
In Treatment of Benign prostatic hyperplasia
When your prostate gland becomes enlarged it can cause urinary problems such as difficulty passing urine and a need to go to the toilet frequently or urgently. It can also cause urine flow to be slower. If not treated, there is a risk that your urine flow will be completely blocked. Temsujohn 0.2mg Tablet ER works by relaxing muscles in the bladder and prostate. So, it can rapidly relieve the symptoms and make it easier for you to urinate. However, it may take up to 6 months to notice the full benefit. Take this medicine exactly as prescribed for maximum benefits.
Side effects of Temsujohn Tablet ER
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Temsujohn
- Dizziness
- Ejaculation disorder
- Headache
- Nausea
- Infection
- Abdominal pain
- Back pain
- Chest pain
- Inflammation of the nose
How to use Temsujohn Tablet ER
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Temsujohn 0.2mg Tablet ER may be taken with or without food, but it is better to take it at a fixed time.
How Temsujohn Tablet ER works
Temsujohn 0.2mg Tablet ER is an alpha blocker. It works by relaxing the muscles around the bladder exit and prostate gland so urine is passed more easily. This helps empty the bladder completely and reduces the need to pass urine frequently or urgently in BPH.
Safety advice
Alcohol
UNSAFE
Temsujohn 0.2mg Tablet ER may cause excessive drowsiness with alcohol.
Pregnancy
CONSULT YOUR DOCTOR
Information regarding the use of Temsujohn 0.2mg Tablet ER during pregnancy is not available. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Temsujohn 0.2mg Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Temsujohn 0.2mg Tablet ER is not indicated for use in women.
Temsujohn 0.2mg Tablet ER is not indicated for use in women.
Driving
SAFE
Temsujohn 0.2mg Tablet ER does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Temsujohn 0.2mg Tablet ER is safe to use in patients with kidney disease. No dose adjustment of Temsujohn 0.2mg Tablet ER is recommended.
However, limited information is available on the use of Temsujohn 0.2mg Tablet ER in patients with end stage kidney disease. Please consult your doctor.
However, limited information is available on the use of Temsujohn 0.2mg Tablet ER in patients with end stage kidney disease. Please consult your doctor.
Liver
CAUTION
Temsujohn 0.2mg Tablet ER should be used with caution in patients with severe liver disease. Dose adjustment of Temsujohn 0.2mg Tablet ER may be needed. Please consult your doctor.
What if you forget to take Temsujohn Tablet ER?
If you miss a dose of Temsujohn 0.2mg Tablet ER, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Temsujohn 0.2mg Tablet ER helps in relieving the symptoms of enlarged prostate. It does not decrease the size of the prostate.
- Temsujohn 0.2mg Tablet ER must be taken with food.
- You will feel better within hours or days of starting the treatment. Full effect is usually seen within 2 weeks.
- Temsujohn 0.2mg Tablet ER may cause dizziness or sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
- If you are scheduled to undergo an eye surgery due to cataract or glaucoma, inform your eye doctor about the usage of Temsujohn 0.2mg Tablet ER.
- Inform your doctor if you have ever been diagnosed with kidney or liver problems.
Fact Box
Chemical Class
Sulfonamide Derivative
Habit Forming
No
Therapeutic Class
UROLOGY
Action Class
Uroselective adrenergic receptor(α1a) antagonist
Patient concerns
FAQs
Q. What is the best time to take Temsujohn 0.2mg Tablet ER?
You can take the capsule after breakfast or after the first meal of the day. However, some doctors prefer it to be taken at night time after dinner. You should take it approximately 30 minutes following the same meal every day. Swallow it as a whole with a glass of water. Do not open, crush or chew the medicine.
Q. Can the use of Temsujohn 0.2mg Tablet ER increase blood sugar levels?
Use of Temsujohn 0.2mg Tablet ER does not increase your blood sugar levels. If you notice any change in the blood sugar levels while taking it, consult your doctor as this could be due to some condition which needs attention.
Q. Does Temsujohn 0.2mg Tablet ER cause weight gain?
No, Temsujohn 0.2mg Tablet ER does not usually cause any increase in the weight, even on long-term use. If you experience any weight gain while taking the medication, then consult your doctor to identify the cause of the weight gain.
Q. When does Temsujohn 0.2mg Tablet ER start to work?
An improvement in urine flow can be seen in 4 to 8 hours after taking Temsujohn 0.2mg Tablet ER. However, it may take 2 to 4 weeks for the full effect to come.
Q. Can I take Temsujohn 0.2mg Tablet ER with vitamin D?
Yes, Temsujohn 0.2mg Tablet ER can be taken with vitamin D. No harmful effects or interactions have been reported when these are used together.
Q. How does Temsujohn 0.2mg Tablet ER help in removal of kidney stones?
In patient with kidney stones, Temsujohn 0.2mg Tablet ER helps in removal of stones via urine. It works by relaxing the muscles of the urinary tract which causes an easy removal of the stones.Use of Temsujohn 0.2mg Tablet ER in kidney stones also decreases the need for painkillers.
Q. Why does Temsujohn 0.2mg Tablet ER cause dizziness?
Temsujohn 0.2mg Tablet ER dilates the blood vessels and leads to the accumulation of blood in the extremities (ends of the arms and limbs). This restrains the proper flow of blood to the brain, thereby causing the blood pressure to fall on the sudden change in posture. As a result, the patient may experience dizziness, lightheadedness, fainting, spinning sensation, and vertigo.
Q. Why should I stop taking Temsujohn 0.2mg Tablet ER before my cataract surgery?
Temsujohn 0.2mg Tablet ER can cause floppy eye syndrome in which the muscles of the iris become floppy and the pupil constricts unexpectedly during cataract surgery. So, when the eye surgeon actually needs a dilated pupil, it will constrict and restrict the field of surgery, and can affect the surgical outcomes.
Q. Why does Temsujohn 0.2mg Tablet ER cause stuffy nose?
Temsujohn 0.2mg Tablet ER relaxes the smooth muscles of the blood vessels and this vasodilation of the blood vessels can cause a stuffy nose.
Q. Is Temsujohn 0.2mg Tablet ER anticholinergic?
No, Temsujohn 0.2mg Tablet ER is not an anticholinergic medication. It is a medicine that acts by relaxing the muscles in the prostate gland and neck of the urinary bladder, improving the urine flow in patients with benign enlargement of the prostate gland. Taking anticholinergic drugs in this condition or while taking Temsujohn 0.2mg Tablet ER can increase the symptoms and worsen the condition.
Q. Can Temsujohn 0.2mg Tablet ER cause frequent urination?
No, Temsujohn 0.2mg Tablet ER does not cause frequent urination. In fact, this medicine increases the urine flow and decreases the urge to urinate frequently, which is a symptom of benign enlargement of the prostate gland. This condition also leads to a weak stream while urinating and hence the patient is not able to empty the bladder completely. Temsujohn 0.2mg Tablet ER is used to treat all such symptoms related to urine flow in patients with benign enlargement of the prostate gland.
Q. What are the long-term effects of taking Temsujohn 0.2mg Tablet ER?
Usually Temsujohn 0.2mg Tablet ER does not cause any side effects in patients with benign enlargement of the prostate gland. However, long-term use of Temsujohn 0.2mg Tablet ER may increase the chances of having infection, rhinitis, pain, and pharyngitis. Its long-term use may also cause abnormal ejaculation, blackouts, faintness, lightheadedness, dizziness, and decreased blood pressure.
Q. Apart from taking medicines, what should I do to manage my prostate symptoms?
Simple lifestyle changes can help you manage your symptoms better. Try to urinate when you first get the urge. However, take care not to strain or push to empty your bladder. Avoid drinking fluids (especially alcohol, caffeine) a few hours before bedtime or going out. Also, you should not take any other medicine without consulting your doctor because some medicines can increase your urge to urinate.
Q. Can I take Temsujohn 0.2mg Tablet ER with ibuprofen or paracetamol?
Temsujohn 0.2mg Tablet ER can be taken with ibuprofen or paracetamol. No harmful side effects or other interactions have been seen when they are taken together.
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Westfall TC, WestfallIn DP. Adrenergic Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 307.
- Robertson D, Biaggioni I. Adrenoreceptor Antagonists Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 153.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1314.
- Tamsulosin. Guildford, Surrey: Zentiva; 2017 [revised 29 Aug. 2018]. [Accessed 04 Apr. 2019] (online) Available from:
- Tamsulosin.Tokyo, Japan: Astellas, Pharma Inc; 2005. [Accessed 04 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). Tamsulosin hydrochloride. [Accessed 04 Apr. 2019] (online) Available from:
- CiplaMed. Tamsulosin hydrochloride [Prescribing Information]. [Accessed 07 Aug. 2023]. (online) Available from:
Marketer details
Name: Johnlee Pharmaceuticals Pvt Ltd
Address: 42/44, Babu Genu Road, Shop No. 06, 2nd Floor, Om Shanti Co-op Housing Society, Kalbadevi Road, Mumbai-400002. (India)
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹65
Inclusive of all taxes
10.0 tablet er in 1 strip
SOLD OUT
Notify me